当前位置: 首页 > 期刊 > 《中国医学创新》 > 202013
编号:13480188
经皮左心耳封堵术的现状(5)
http://www.100md.com 2020年5月5日 《中国医学创新》 202013
     [24]汤学超,白元,张志钢,等.左心耳封堵器临床研究进展[J].介入放射学杂志,2017,26(3):281-284.

    [25] Holmes D R,Kar S,Price M J,et al.Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients with Atrial FibrillationVersus Long-Term War far in Therapy:The PREVAIL Trial[J].Journal of the American College of Cardiology,2014,64(1):1-12.

    [26] Lam Yat-Yin.A new left atrial appendage occluder(Lifetech LAmbre TM Device)for stroke prevention in atrial fibrillation[J].Cardiovascular Revascularization Medicine,2013,14(3):134-136.

    [27]朱璟晶,儲慧民.LAmbre(TM)左心耳封堵器在心房颤动卒中预防应用中的最新进展[J].现代实用医学,2019,31(3):151-154.

    [28]刘育,黄鹤.左心耳封堵器械研发:历史、现在和未来[J].心血管病学进展,2019,40(4):502-504.

    [29] Fauchier L,Cinaud A,Brigadeau F,et al.Device-Related Thrombosis after Percutaneous Left Atrial Appendage Occlusionfor Atrial Fibrillation[J].Journal of the American College of Cardiology,2018,71(14):1528.

    [30] Kaneko H,Neuss M,Weissenborn J,et al.Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device[J].Heart Vessels,2017,32(9):1137-1143.

    [31]姚焰.必须严格掌握左心耳封堵术的适应证[J].中华心血管病杂志,2018,46(8):595-597.

    (收稿日期:2019-10-30) (本文编辑:周亚杰), 百拇医药(孙启帆 吴铿)
上一页1 2 3 4 5